The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in Italy by Anna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, Alen Marijam, Giovanna Elisa Calabró

Get full text

How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future by Baudouin Standaert, Christophe Sauboin, Rodrigo DeAntonio, Alen Marijam, Jorge Gomez, Lijoy Varghese, Sharon Zhang

Get full text

Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany by Maria Waize, Pavo Marijic, Alen Marijam, Foteini Gkalapi, Elisa Turriani, Franziska Jakobs, Indra Jaidhauser, Dorothea Münch, Sara Pedron, Eleftherios Zarkadoulas

Get full text

Healthcare Resource Utilization and Economic Outcomes of RSV-Hospitalized Patients Aged ≥ 60 Years: A Retrospective Cohort Study by Anna Puggina, Melania Dovizio, Alexander Domnich, Alen Marijam, Chiara Veronesi, Caterina Rizzo, Marta Vicentini, Luca Degli Esposti, Giovanna Elisa Calabrò, Maria João Fonseca

Get full text

Demographics and clinical burden of disease among RSV-hospitalized older adults in Italy: A retrospective cohort study by Anna Puggina, Melania Dovizio, Alexander Domnich, Alen Marijam, Chiara Veronesi, Caterina Rizzo, Marta Vicentini, Luca Degli Esposti, Giovanna Elisa Calabrò, Maria João Fonseca

Get full text

Estimating the respiratory syncytial virus-associated hospitalisation burden in older adults in European countries: a systematic analysis by Tiantian Zhang, Rachel M. Reeves, Shihao Ma, Yumeng Miao, Shiqi Sun, Alejandro Orrico-Sánchez, Marcus Panning, Arantxa Urchueguía-Fornes, Danielle Vuichard-Gysin, Harish Nair, Maria João Fonseca, Alen Marijam, Xin Wang, You Li, Respiratory Virus Global Epidemiology Network

Get full text